College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies

Christina M. Wojewoda; Neil W. Anderson; Romney M. Humphries; Isabella W. Martin; Blaine A. Mathison; Allison R. McMullen; Frederick S. Nolte; David R. Peaper; Dylan R. Pillai; Carol A. Rauch; Dan D. Rhoads; Susan E. Sharp; Rosemary C. She; Patricia J. Simner; Kaede V. Sullivan; Elitza S. Theel; Angela M. Theiss; Richard B. Thomson; Bobbi S. Pritt

doi:10.1128/JCM.02105-19

College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies

Christina M. Wojewoda, Neil W. Anderson, Romney M. Humphries, Isabella W. Martin, Blaine A. Mathison, Allison R. McMullen, Frederick S. Nolte, David R. Peaper, Dylan R. Pillai, Carol A. Rauch, Dan D. Rhoads, Susan E. Sharp, Rosemary C. She, Patricia J. Simner, Kaede V. Sullivan, Elitza S. Theel, Angela M. Theiss, Richard B. Thomson, Bobbi S. Pritt

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e02105-19
Journal	Journal of clinical microbiology
Volume	58
Issue number	4
DOIs	https://doi.org/10.1128/JCM.02105-19
State	Published - 2020

Keywords

Antimicrobial agents
Susceptibility testing

ASJC Scopus subject areas

Microbiology (medical)

Access to Document

10.1128/JCM.02105-19

Cite this

Wojewoda, C. M., Anderson, N. W., Humphries, R. M., Martin, I. W., Mathison, B. A., McMullen, A. R., Nolte, F. S., Peaper, D. R., Pillai, D. R., Rauch, C. A., Rhoads, D. D., Sharp, S. E., She, R. C., Simner, P. J., Sullivan, K. V., Theel, E. S., Theiss, A. M., Thomson, R. B., & Pritt, B. S. (2020). College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies. Journal of clinical microbiology, 58(4), Article e02105-19. https://doi.org/10.1128/JCM.02105-19

Wojewoda, CM, Anderson, NW, Humphries, RM, Martin, IW, Mathison, BA, McMullen, AR, Nolte, FS, Peaper, DR, Pillai, DR, Rauch, CA, Rhoads, DD, Sharp, SE, She, RC, Simner, PJ, Sullivan, KV, Theel, ES, Theiss, AM, Thomson, RB & Pritt, BS 2020, 'College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies', Journal of clinical microbiology, vol. 58, no. 4, e02105-19. https://doi.org/10.1128/JCM.02105-19

@article{ab943dcad5db42e2abecb3ccdc6558ef,

title = "College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies",

keywords = "Antimicrobial agents, Susceptibility testing",

author = "Wojewoda, {Christina M.} and Anderson, {Neil W.} and Humphries, {Romney M.} and Martin, {Isabella W.} and Mathison, {Blaine A.} and McMullen, {Allison R.} and Nolte, {Frederick S.} and Peaper, {David R.} and Pillai, {Dylan R.} and Rauch, {Carol A.} and Rhoads, {Dan D.} and Sharp, {Susan E.} and She, {Rosemary C.} and Simner, {Patricia J.} and Sullivan, {Kaede V.} and Theel, {Elitza S.} and Theiss, {Angela M.} and Thomson, {Richard B.} and Pritt, {Bobbi S.}",

note = "Funding Information: ACKNOWLEDGMENTS This letter was submitted with approval from the College of American Pathologists. Dr. Romney M. Humphries is employed by Accelerate Diagnostics, Inc., and owns stocks in the company. Dr. Richard B. Thomson serves as a consultant for Accelerate Diagnostics, Inc., and is the Chair of the Microbiology Expert Panel for the CLSI. Dr. Dan D. Rhoads receives research funding for work on novel antibacterial agents through Shionogi Inc., Tetraphase Pharmaceuticals Inc., and Venatorx Pharmaceuticals. The other authors have no relevant conflicts of interest.",

year = "2020",

doi = "10.1128/JCM.02105-19",

language = "English (US)",

volume = "58",

journal = "Journal of clinical microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - College of American Pathologists (CAP) microbiology committee perspective

T2 - The need for verification studies

AU - Wojewoda, Christina M.

AU - Anderson, Neil W.

AU - Humphries, Romney M.

AU - Martin, Isabella W.

AU - Mathison, Blaine A.

AU - McMullen, Allison R.

AU - Nolte, Frederick S.

AU - Peaper, David R.

AU - Pillai, Dylan R.

AU - Rauch, Carol A.

AU - Rhoads, Dan D.

AU - Sharp, Susan E.

AU - She, Rosemary C.

AU - Simner, Patricia J.

AU - Sullivan, Kaede V.

AU - Theel, Elitza S.

AU - Theiss, Angela M.

AU - Thomson, Richard B.

AU - Pritt, Bobbi S.

N1 - Funding Information: ACKNOWLEDGMENTS This letter was submitted with approval from the College of American Pathologists. Dr. Romney M. Humphries is employed by Accelerate Diagnostics, Inc., and owns stocks in the company. Dr. Richard B. Thomson serves as a consultant for Accelerate Diagnostics, Inc., and is the Chair of the Microbiology Expert Panel for the CLSI. Dr. Dan D. Rhoads receives research funding for work on novel antibacterial agents through Shionogi Inc., Tetraphase Pharmaceuticals Inc., and Venatorx Pharmaceuticals. The other authors have no relevant conflicts of interest.

PY - 2020

Y1 - 2020

KW - Antimicrobial agents

KW - Susceptibility testing

UR - http://www.scopus.com/inward/record.url?scp=85082505514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082505514&partnerID=8YFLogxK

U2 - 10.1128/JCM.02105-19

DO - 10.1128/JCM.02105-19

M3 - Letter

C2 - 32213577

AN - SCOPUS:85082505514

SN - 0095-1137

VL - 58

JO - Journal of clinical microbiology

JF - Journal of clinical microbiology

IS - 4

M1 - e02105-19

ER -

College of American Pathologists (CAP) microbiology committee perspective: The need for verification studies

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this